Between 12 and 30 months , continued thienopyridine reduced stent thrombosis compared with placebo in patients with and without MI at presentation ( MI group , 0.5 % vs. 1.9 % , p < 0.001 ; no MI group , 0.4 % vs. 1.1 % , p < 0.001 ; interaction p = 0.69 ) .